What is the best regimen of antithrombotic therapy for AF patients with ACS and/or PCI?

Professor Storey describes how the AUGUSTUS study data has given insights into dual therapy with anticoagulant and P2Y12 antagonist vs. triple therapy with aspirin, P2Y12 inhibitor and an oral anticoagulant and how best to individualise therapy according to the risks of stroke and stent thrombosis.